Part time Trader, Part time Musician, Part time Prince, Always Charming
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yet the stock keeps tanking...
That market can be a cruel place at times.
I have high hopes also.
GLTA
Uh oh....
Anyone look at Coventry Enterprises?
You know, the group that bought all those shares.
I did.
https://www.coventryenterprises.com/
Google it too.
I did.
Good luck.
Pretty brutal couple of days...
Down another 17% today. Almost back to my buy in levels. Someone know something we don’t? A turn around would be nice but I don’t expect anything on a Friday.
This almost has the smell of a penny stock pump and dump..
GLTA
8 year old article. Way to stay current. Maybe you didn’t think anyone would notice?
Nice try. I’m not a big fan here either but I don’t try to mislead people.
Might be an ugly day....
Novavax has been cut to Neutral from Buy by Citigroup.
Good luck.
What happened to the volume? Everyone already got their shares?
Bought on the pull back.
Hard to resist at these prices. This is a commodity everyone uses. How can it not go back up?
GLTA
How low will it go?
I might buy back in on the dip. This stock has always made me money so why should this time be any different.
So did you sell?
After advising everyone to sell, I was wondering if you sold and missed today's nice bump?
Or do you have other plans?
Nice bounce today.
Let's see if it holds.
Nice rise on news
Why are you posting a link to something that is over a year and a half old?
Curious minds and all that....
Brutal day today.
Thanks for the link and info.
Doesn't it seem to be a bit self-serving to have a favorable review of yourself published by the company you work for? Must be a variant on the "good ol boy's club" I guess.
GLTA
-Bob-
One guy doesn't like the stock
According to "Benzinga", a biotech "expert" named Adam Feuerstein put out an unfavorable tweet.
"$NVAX positive top line data relate to safety and immunogenicity of RSV vaccine, not efficacy. Smoke, meet mirror". @adamfeuerstein July 24, 2017
Who the hell is this Adam dude and what makes him an expert. Oh wait, he's a reporter for some rag named "STAT News".
That explains everything... NOT
Nice run today.
Be nice to see this trend continue.
GLTA
Thanks for the welcome.
Small investor but big on USAT.
GLTA
This stock is getting hammered today.
Guess it was to be expected.
14+ percent drop today...
Who knows something we don't ??
With thanks to xyz007...
Here is the complete link for those interested in what Seeking Alpha had to say about TherapeuticsMD. Easier to click on a complete link.
https://seekingalpha.com/article/4086023-profit-therapeuticsmds-upcoming-fda-catalyst
Can you provide a link?
I am a member of SA but I cannot find any reference to the article you quote. FDA approval would be sweet. Thanks in advance.
Must have been a good meeting
The stock is up over 15% as I write this at 12:30 EDT. I do wish I could get more timely news on this company. Looks like a nice bounce but how long and how high??
GLTA
Another Fresh 52 Week Low
What will we see going forward? Trips? Reverse Split? Bankruptcy? It seems we going to see more share dumping so my guess is the first two and then, after it is milked completely, the last one.
What a POS stock.
Up nicely today.
Any news out there that is taking this up? I'd like it to go a lot higher, say pre-crash pricing but that might take a while.
GLTA
Anyone ever hear of the "International Security Group" before this so called "news"? It seems to have little or negative effect on this POS of a stock.
This latest pump and dump did poorly.
This stock has had more pump and dump schemes than any I can remember. This one only netted about 20% and lasted a very short time. Probably disappointing to most of the players. Anyone notice that the few new people that have posted here in the past couple of weeks are no longer around? They were telling anyone they could that this POS was the best thing since sliced bread and now... well, all gone right along with that 20% boost in the share price.
This stock has been and probably will always be crap. The company is a poster child for mismanagement with broken promises, no performance and little to offer. Anyone who bought into the hype and are now underwater could just wait for the next pump and dump scheme. Not to worry, it'll happen.
Bankruptcy filed. Good luck. eom
Well, Here's the News and it ain't pretty
Unilife Reduces Workforce By 51 Employees, Expects To Record Charge Of ~$0.6M, Believes Existing Cash Will Not Provide Co. With Sufficient Liquidity To Fund Operations Past Week Ending April 7th (Benzinga)
After hours trading has this turd at $0.41 down from $1.25 at the close. Everyone is bailing.
Ah well...
Another Fresh New 52 Week Low Today
What a disappointment. This turd is sinking to the bottom and it doesn't look like anything will save it. I should have seen this coming.
GLTA. You'll need it.
No volume.
The pump has ended and failed again. This pump never grew much of any legs. People hopefully are getting wise to this POS.
I hope I am wrong but I see no hope for this at all.
For grins, every time I see a post from NutraPharma on Twitter, I am going to respond with a question about their stock performance. Good times....
Nutra Pharma Corporation Featured on NBC News Miami
Tonight Feb-14-2017 at 11pm
Nutra Pharma’s over the counter (OTC) products, Nyloxin® and Pet Pain-Away™, wlll be featured on the NBC News Miami affiliate (www.nbcmiami.com) at 11pm tonight; February 14, 2017.
"NBC News has been featuring the use of natural products for the treatment of a variety of ailments," commented Rik J Deitsch, CEO of Nutra Pharma. “For the most part, these reports have discussed the use of marijuana. Nutra Pharma’s Nyloxin has been shown to be just as potent as opiate pain relievers without the side effects caused by the use of opiates or marijuana," he continued. "The report focusses on Nyloxin and Pet Pain-Away. These are clinically proven, legal and all-natural products that are available today to deal with pain and inflammation in people and their pets," he concluded.
The interview was conducted by Jamie Guirola with filming at Nutra Pharma’s laboratory facility and the reptile farm that houses their cobras for venom production. Jamie, through his interviews, learned about cobra venom and its use as a potent pain-reliever (analgesic) and anti-inflammatory agent.
Ok... So what does Rik expect to happen now??
NPHC is getting more active
Not sure why but I have been seeing a lot more activity from Rik and the boys on Facebook and Twitter. I have no idea what the thought process is behind it but I have seen new posts at least once a week or more on social media. Maybe he is looking for a younger, more hip crowd. Who knows?
GLTA
Letter to shareholders from Rik
NEWSROOM
Nutra Pharma Letter to Shareholders
December 27, 2016
Nutra Pharma CEO, Rik J Deitsch, has published a letter to Shareholders outlining the current efforts and the future goals of the Company.
December 27, 2016 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain announced today that the Company's Chief Executive Officer, Rik J Deitsch, has published a Shareholder Letter on the Company's website.
“As always, we have been very busy at Nutra Pharma,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “2016 has been a watershed year for the company; we have been bringing in new management, new Directors and consultants to pave the way for real growth in 2017," he continued. "I wanted to take this opportunity to update our shareholders and the public on the accomplishments of the year, the status of the Company and briefly outline our goals and expectations for the coming months,” he concluded.
The letter includes some of the following accomplishments made by the Company over the past year:
• We expanded our Management team by bringing in Tri-State Capital Partners to help increase sales of our OTC products and work on potential sales to the US Government and Military.
• We named Thomas W. Northrop as the Company's Senior Commercial Development Officer.
• We appointed Dan Oran as our newest member of our Board of Directors.
• We appointed Dale Vanderputten, PhD as our Chief Scientific Officer (CSO).
• We announced a manufacturing alliance with Omnia Biologics to clone and produce alpha-cobratoxin for the production of RPI-78M for upcoming clinical trials in Pediatric Multiple Sclerosis.
• We announced an agreement with DEG Productions for the marketing and distribution of our Over the Counter (OTC) drug for the treatment of pain in companion animals, Pet Pain-Away™.
• We announced the initiation of an infomercial test campaign of Pet Pain-Away™.
The Shareholder Letter is available on the Company's website at: http://www.nutrapharma.com/Dec2016_shareholder_letter.pdf
About Nutra Pharma Corp.
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brands: Nyloxin® and Pet Pain-Away™. For additional information about Nutra Pharma, visit:
http://www.NutraPharma.com or
http://www.nyloxin.com
http://www.petpainaway.com
SEC Disclaimer
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The publication of this Shareholder Letter should not be construed as an indication in any way whatsoever of the future value of the Company’s common stock or its financial value. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
So why is this down today?
No news that I can find and this POS is down 12% today. Quick, someone tell me this is a buying opportunity.
It's up because the pump is working
Those of us that have been here more than the 2 months you have, have seen this all before. This has the smell of another pump and dump scam written all over it. They did TV advertisements before but again, a scam. I think it was about 2011 when they put out a press release that they were going to advertise the hell out of Nyloxin and would start in "select" markets. They made about 3 ads and they were very much like the style of the one made recently. The commercials ran for a very limited time on the Golf Channel in Florida and were never seen again. Anyone here ever see any of them?
I must admit that there was excitement back in 2009 when NPHC teamed with XenaCare and their product actually made it to the shelves of Walgreens, CVS and others. Of course, that deal imploded and since then Rik has messed up one business deal after another.
Some of you talk about buying product today. You do realize that stuff is probably more than 2 years old. Good luck finding any date on the bottles you buy. NPHC and it's scam multi level marketing schemes are selling old product to clear what inventory they have from years back. Glad the "product" is working for some of you though. Better stock up.
I wish I was wrong. There are old posts from me much like yours where I am hoping that the company would do well. Too many times this piece of shit has disappointed though. I see nothing here that would make me think this time is different.
But with all that, good luck and take any profits when you can, if you can. This is a trading stock, not an investment.
What competition?
If I am getting the correct link, it's an article on the "Blue Coral" cobra snake, not any company. The article goes on to tell of the benefits of using cobra snake venom for pain. No where did I see mention of a competing company. Did I see the right link? If anything, this article would call attention to cobra snake products and possibly be helpful to NPHC.
GLTA
Works for me...
I have been using the product in it's various strengths for years. It's getting a bit pricey with the shipping and all but I still get a bottle every other month or so.
Too bad about the company though. It seems they (Rik) have done everything possible to drive this into the ground. I have zero faith that there is going to be any kind of turnaround in my life time. The PPS has to have a 12 fold increase just for me to break even in this round. I don't see that happening anytime soon.
GLTA
What News?
Wouldn't it be nice if we all could get the news that moved this stock all at the same time. Someone or some group knows something and I ain't in the loop. Then again, as my wife says, it's all rigged... so there's that.
GLTA